Comfrey for Wound Healing

Research suggests that comfrey, particularly its key bioactive compounds such as allantoin, rosmarinic acid, and related phenolics, shows meaningful wound-healing potential across multiple study types, including one randomized controlled trial in children with abrasions that found a higher-concentration comfrey cream accelerated healing significantly compared to a lower-dose control, as well as supportive findings from animal studies, in vitro cell work, and several reviews of the broader ethnobotanical and clinical literature. Studies indicate that comfrey may promote wound repair through several mechanisms, including stimulating collagen deposition, reducing inflammatory activity, supporting fibroblast viability and migration, and — in the case of L-shikonin, a comfrey-derived compound — potentially modulating immune cell behavior and vascularization in preclinical diabetic wound models. The evidence base, while generally pointing in a supportive direction, is largely preclinical or limited in scale, and the most rigorous clinical data comes from a single pediatric trial, meaning broader conclusions about efficacy in adults or diverse wound types remain premature. A notable safety concern runs through this literature as well: comfrey contains pyrrolizidine alkaloids, which separate laboratory studies link to liver cell toxicity through mitochondrial and endoplasmic reticulum stress pathways, though one 2024 study found that skin microbiota may partially break down these compounds during topical application in ways that could reduce — though not eliminate — that risk.